Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Maintaining The Status Quo For ESAs In Chronic Renal Disease

Executive Summary

The Centers for Medicare and Medicaid Services has decided not to proceed with a national coverage determination for erythropoiesis-stimulating agents in patients with chronic kidney disease, according to a proposed decision memo released March 16.
Advertisement

Related Content

Genetic Testing, But No Drugs, On Revised List Of Potential Medicare NCD Topics
Targeted Drugs With Companion Dx May Draw Medicare NCD Interest – Phurrough
Targeted Drugs With Companion Dx May Draw Medicare NCD Interest – Phurrough
Medicare Response To ESA "Overuse" In CKD Will Await Impact Of Bundled Payments, CMS Says
A Closer Look: Decision For No Medicare NCD On ESAs In Renal Disease Would Be The Exception
A Closer Look: Decision For No Medicare NCD On ESAs In Renal Disease Would Be The Exception
ESA Data On Survival Benefit In Renal Transplant Grafts Are Insufficient - Medicare Panel
Delaying Inclusion Of Oral-Only ESRD Drugs In Bundled Payment Gives Short-Term Reprieve To Genzyme, Amgen
Delaying Inclusion Of Oral-Only ESRD Drugs In Bundled Payment Gives Short-Term Reprieve To Genzyme, Amgen

Topics

Advertisement
UsernamePublicRestriction

Register

PS053222

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel